| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.2 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in jotron StudyMD 0.3.2. Affected by this issue is some unknown functionality of the component Markdown File Handler. Executing a manipulation can lead to cross site scripting. This vulnerability is registered as CVE-2021-47842. It is possible to launch the attack remotely. Furthermore, an exploit is available.
Details
A vulnerability classified as problematic was found in jotron StudyMD 0.3.2. This vulnerability affects an unknown functionality of the component Markdown File Handler. The manipulation with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
StudyMD 0.3.2 contains a persistent cross-site scripting vulnerability that allows attackers to inject malicious scripts into markdown files. Attackers can upload crafted markdown files with embedded JavaScript payloads that execute when the file is opened, potentially enabling remote code execution.
The weakness was published by TaurusOmar as 49832. The advisory is available at exploit-db.com. This vulnerability was named CVE-2021-47842 since 01/14/2026. The exploitation appears to be easy. The attack can be initiated remotely. Successful exploitation requires user interaction by the victim. Technical details are unknown but a public exploit is available. This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.
It is possible to download the exploit at exploit-db.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at Exploit-DB (49832). If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.2
VulDB Base Score: 3.5
VulDB Temp Score: 3.2
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 7.2
CNA Vector (VulnCheck): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Access: Public
Status: Proof-of-Concept
Download: 🔒
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Exploit-DB: 🔒
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
01/14/2026 CVE reserved01/16/2026 Advisory disclosed
01/16/2026 VulDB entry created
01/16/2026 VulDB entry last update
Sources
Advisory: 49832Researcher: TaurusOmar
Status: Not defined
CVE: CVE-2021-47842 (🔒)
GCVE (CVE): GCVE-0-2021-47842
GCVE (VulDB): GCVE-100-341650
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 01/16/2026 20:31Changes: 01/16/2026 20:31 (80)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.